Clinical Trial Update: REBECCA Study (RadiothErapy for BrEast Cancer and CArdiotoxicity) [NA]

View source ↗

Summary

The REBECCA study, investigating radiotherapy-related cardiotoxicity in breast cancer, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Sophie JACOB | Conditions: Toxicity Due to Radiotherapy, Breast Cancer | NA | Status: WITHDRAWN